During the last consortium meeting of MIROCALS held on June 7th and 8th 2018 in the Humanitas Congress Centre in Milano (Italy), the progress made since the beginning of the project were presented.
During the last consortium meeting of MIROCALS held on June 7th and 8th 2018 in the Humanitas Congress Centre in Milano (Italy), the progress made since the beginning of the project were presented.
The MIROCALS (Modifying Immune Response and Outcomes in ALS) Clinical Trial is still on-going, with recruitment continuing until the end of September 2019.
Read moreClinical trials are expensive to run and with several more neurology clinics taking part, ...
Read moreAs with everything else affected by Brexit, there are probably more questions than answers!
Read more
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633413.